Response to: 'Acquiring new N- glycosylation sites in variable regions of immunoglobulin genes by somatic hypermutation is a common feature of autoimmune diseases' by Visser et al
- PMID: 29170200
- DOI: 10.1136/annrheumdis-2017-212583
Response to: 'Acquiring new N- glycosylation sites in variable regions of immunoglobulin genes by somatic hypermutation is a common feature of autoimmune diseases' by Visser et al
Keywords: autoimmune diseases; b cells; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation.Ann Rheum Dis. 2018 Jun;77(6):956-958. doi: 10.1136/annrheumdis-2017-212052. Epub 2017 Aug 23. Ann Rheum Dis. 2018. PMID: 28835463 No abstract available.
-
Acquiring new N-glycosylation sites in variable regions of immunoglobulin genes by somatic hypermutation is a common feature of autoimmune diseases.Ann Rheum Dis. 2018 Oct;77(10):e69. doi: 10.1136/annrheumdis-2017-212568. Epub 2017 Nov 4. Ann Rheum Dis. 2018. PMID: 29102958 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
